fluphenazine has been researched along with Pneumonia, Viral in 3 studies
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sinha, S | 1 |
Cheng, K | 1 |
Schäffer, AA | 1 |
Aldape, K | 1 |
Schiff, E | 1 |
Ruppin, E | 1 |
Nazeam, J | 1 |
Mohammed, EZ | 1 |
Raafat, M | 1 |
Houssein, M | 1 |
Elkafoury, A | 1 |
Hamdy, D | 1 |
Jamil, L | 1 |
Otręba, M | 1 |
Kośmider, L | 1 |
Rzepecka-Stojko, A | 1 |
2 reviews available for fluphenazine and Pneumonia, Viral
Article | Year |
---|---|
Based on Principles and Insights of COVID-19 Epidemiology, Genome Sequencing, and Pathogenesis: Retrospective Analysis of Sinigrin and Prolixin
Topics: Antiviral Agents; Bayes Theorem; Biological Products; Coronavirus; COVID-19; COVID-19 Drug Treatment | 2020 |
Antiviral activity of chlorpromazine, fluphenazine, perphenazine, prochlorperazine, and thioridazine towards RNA-viruses. A review.
Topics: Animals; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Chlorpromazine; Coronavirus Infect | 2020 |
1 other study available for fluphenazine and Pneumonia, Viral
Article | Year |
---|---|
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
Topics: A549 Cells; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Convertin | 2020 |